Surgery Partners, Inc. $SGRY Shares Sold by MidWestOne Financial Group Inc.

MidWestOne Financial Group Inc. lowered its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 21.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 159,146 shares of the company’s stock after selling 44,614 shares during the period. MidWestOne Financial Group Inc. owned approximately 0.12% of Surgery Partners worth $3,444,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Jones Financial Companies Lllp raised its stake in shares of Surgery Partners by 313.1% during the third quarter. Jones Financial Companies Lllp now owns 1,227 shares of the company’s stock valued at $27,000 after purchasing an additional 930 shares in the last quarter. AlphaQuest LLC raised its position in shares of Surgery Partners by 94.4% during the 2nd quarter. AlphaQuest LLC now owns 2,057 shares of the company’s stock worth $46,000 after buying an additional 999 shares in the last quarter. FNY Investment Advisers LLC bought a new stake in shares of Surgery Partners during the 2nd quarter worth about $115,000. State of Alaska Department of Revenue acquired a new stake in shares of Surgery Partners in the 3rd quarter worth approximately $151,000. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Surgery Partners by 68.7% in the second quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock valued at $207,000 after acquiring an additional 3,794 shares in the last quarter.

Surgery Partners Stock Down 0.2%

Shares of Surgery Partners stock opened at $15.46 on Friday. Surgery Partners, Inc. has a 12-month low of $13.14 and a 12-month high of $26.16. The firm has a market capitalization of $2.00 billion, a PE ratio of -11.37 and a beta of 1.97. The company has a quick ratio of 1.72, a current ratio of 1.88 and a debt-to-equity ratio of 1.10. The stock’s fifty day moving average is $15.45 and its 200-day moving average is $18.92.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. JPMorgan Chase & Co. dropped their target price on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a report on Monday, November 24th. Royal Bank Of Canada dropped their price objective on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 11th. Barclays decreased their target price on Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, November 21st. UBS Group dropped their price target on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, November 13th. Finally, Mizuho cut their price target on shares of Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Thursday, December 18th. Seven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Surgery Partners has an average rating of “Moderate Buy” and a consensus price target of $27.11.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.